Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Operating Expenses: 2019-2024

Historic Operating Expenses for Biodesix (BDSX) over the last 6 years, with Dec 2024 value amounting to $105.8 million.

  • Biodesix's Operating Expenses rose 7.77% to $28.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $112.7 million, marking a year-over-year increase of 12.41%. This contributed to the annual value of $105.8 million for FY2024, which is 17.02% up from last year.
  • Per Biodesix's latest filing, its Operating Expenses stood at $105.8 million for FY2024, which was up 17.02% from $90.4 million recorded in FY2023.
  • Biodesix's 5-year Operating Expenses high stood at $105.8 million for FY2024, and its period low was $68.5 million during FY2020.
  • For the 3-year period, Biodesix's Operating Expenses averaged around $95.0 million, with its median value being $90.4 million (2023).
  • As far as peak fluctuations go, Biodesix's Operating Expenses skyrocketed by 39.36% in 2021, and later decreased by 6.96% in 2022.
  • Over the past 5 years, Biodesix's Operating Expenses (Yearly) stood at $68.5 million in 2020, then surged by 39.36% to $95.4 million in 2021, then dropped by 6.96% to $88.8 million in 2022, then increased by 1.84% to $90.4 million in 2023, then increased by 17.02% to $105.8 million in 2024.